Investing.com-- Asian stocks kept to a tight range on Monday with a bulk of major markets in the region closed for the Chinese New Year, while losses in pharmaceutical giant CSL , after the biopharmaceutical giant said a phase 3 trial for a heart attack drug had failed to meet its primary endpoint for efficacy.
Losses in CSL, which is the third-largest stock on the ASX by market capitalization, offset strong gains in ANZ Group Holdings Ltd will also be removed; self-promotional material or business-related solicitations or PR , and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
{username} Just Now Share Follow this postUnfollow this post Save Saved. See Saved Items . This comment has already been saved in your Saved Items Author's response{commentContent} Reply 00 Report {username} Just NowAuthor's response Share Follow this postUnfollow this post Save Saved. See Saved Items .